登录 | 注册    关注公众号  
微信公众号
搜索
 > 【IgG】

IgG信息

英文名称:Immunoglobulin G
中文名称:免疫球蛋白G
靶点别称:Immunoglobulin G
上市药物数量:1
临床药物数量:5
最高研发阶段:批准上市

IgG产品列表

ACRO质量管理体系
 
评论(2)
IGG-LY69|HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb
  1. 178XXXXXXX8
  2. 5人赞
  3. 用于elisa显色和ads-page 和WB实验,可特异性结合目标检测抗体,背景低,无非特异性结合,结果稳定可靠。
  4. 2022-12-02
IGG-LY69|HRP conjugated Anti-Human-IgG-Fc Antibody (6F11C8), mAb
  1. 186XXXXXXX1
  2. 3人赞
  3. 用于elisa检测humanFc的浓度,该产品作为二抗非常好用,发货速度快,比其它外国品牌速度快很多,一般着急的实验,我都会选择来acro看看。
  4. >
  5. 2024-01-17
 

IgG分子别名

IgG

IgG分子背景

The Anti-Human IgG-Acridine Ester is an acridinium ester labeled Monoclonal mouse anti-human IgG antibody can be used to capture the human IgG in Chemiluminescence procedures.
The antibody reacts with the Fc portion of human IgG heavy chain but not with the Fab portion of human IgG. No antibody was detected against human IgM or IgA, or against non-immunoglobulin serum proteins. The antibody has been tested by ELISA and/or solid-phase adsorbed to ensure minimal cross-reaction with mouse, cynomolgus and bovine serum proteins, but it is not sure if the product cross-react with immunoglobulins from other species.
Acridinium ester is one of the most commonly used excited substrates for protein labeling and widely used in automated instruments because of its high sensitivity with detection limits in the attomole range. Acridinium ester can be triggering by chemiluminescent substrate solution and generate intense signal, the result signals (relative light units, RLU) can be measured at 430 nm.
The Anti-human IgG-Acridine Ester is easy to capture the human IgG, and the bounded human IgG have no activity lost, this ready to use products could greatly save your protein labeling time and hassle, and help us get the best performance and highly reproducible results.

IgG上市药物信息

英文名称 中文名称 研发代码 研发阶段 公司 最早商品名 最早批准国家 最早适应症 最早批准公司 最早批准日期 适应症 临床试验
Imlifidase Mac-1 批准上市 Hansamed Inc Idefirix EU 肾脏移植排斥 Hansa Biopharma Ab 2020-08-25 肾脏移植排斥, 肾脏疾病, 血栓性血小板减少性紫癜, 器官移植排斥, 慢性肾功能不全, 格林-巴利综合征, 终末期肾脏病 详情

IgG临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
Ricefidase KJ-103; KJ103 临床三期 上海宝济药业股份有限公司 肾脏移植排斥, 肺出血肾炎综合征 详情
AT-02 AT-02 临床二期 Attralus Inc 淀粉体轻链淀粉样变性, 淀粉样变 详情
BHV-1300 BHV-1300 临床一期 Biohaven Pharmaceuticals Inc 类风湿关节炎 详情
HNSA-5487 HNSA 5487; HNSA-5487 临床一期 Hansa Biopharma Ab 肿瘤, 自身免疫疾病 详情
Anti-CD33/anti-FcgammaRI bispecific antibody (UCSD) 临床一期 圣迭戈加利福尼亚大学 急性髓细胞样白血病 详情

消息提示

请输入您的联系方式,再点击提交!

确定